Business
NYU-Bracco pact targets AI and advanced imaging research
The multiyear agreement will focus on MRI, photon-counting CT, targeted ultrasound, and AI-enabled PET/CT and MRI image analysis.
Company
Bracco
Italian healthcare company headquartered in Milan, specializing in diagnostic imaging contrast agents and medical solutions across X-ray, CT, MRI, ultrasound, and nuclear medicine. Bracco Imaging is a subsidiary of the Bracco Group.
Business
Canada adds Vueway to macrocyclic MRI contrast options
The approval covers Vueway injection, a macrocyclic gadolinium-based contrast agent for contrast-enhanced MRI in adults and children 2 years and older.